Consultations are generally offered in French: please confirm with the clinic (579 305-0344). The French version of this site prevails. Translation under professional review.
Hormone therapy Saint‑HyacintheHormonal health
Hormonal health and hormone therapy in Saint-Hyacinthe
A comprehensive approach to your health, not just your hormones
At Clinique IPS du Palais, we believe that symptoms associated with perimenopause and menopause should not be assessed in isolation.
Fatigue, disrupted sleep, hot flashes, mood changes, brain fog, vaginal discomfort, weight changes, decreased libido or metabolic changes can sometimes occur at the same time, but they are not necessarily all caused by hormones.
Our approach therefore begins with understanding your situation as a whole.
During your consultation, the nurse practitioner (NP) takes the time to assess your symptoms, your medical history, your personal and family history, your lifestyle habits, your medications, your cardiovascular and metabolic health and your goals.
Hormone therapy may then be one of the options offered when it is relevant, but it is never considered an automatic answer to all symptoms.
Our vision of hormone therapy
Four principles for good care
For us, good hormonal care rests on four principles:
1
Understand before treating
Two patients of the same age can have very different symptoms and not have the same risk factors.
We therefore try to determine what may truly be related to the hormonal transition and what warrants a different investigation.
Tests or additional examinations may be ordered when the clinical situation warrants.
2
Individualize treatment
There is no one-size-fits-all hormone therapy.
The choice of treatment must take into account, among other things:
symptoms;
age;
the timing of the menopausal transition;
whether or not the uterus is present;
personal and family history;
cardiovascular and thromboembolic risk factors;
the patient’s preferences;
expected benefits and possible risks.
This individualization reflects the current recommendations of the Society of Obstetricians and Gynaecologists of Canada, which recommends tailoring hormone therapy to each patient’s symptoms, history, risks, goals and preferences.1
3
Treat when relevant
Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms such as hot flashes and night sweats.
In women without contraindications, the benefit-risk balance is generally favourable when it is started before age 60 or within ten years of the onset of menopause.1
But some patients will benefit more from a non-hormonal treatment, a local treatment or another approach.
Our role is therefore not to convince you to take hormones. It is to help you understand the various options and make an informed decision with your NP.
4
Reassess over time
Hormone therapy should not simply be prescribed and then renewed automatically for years.
Symptoms change. Needs change. Risk factors can also change.
Current recommendations therefore favour periodic reassessment of the treatment, its benefits and its risks rather than a universal duration imposed on all patients.1, 2
When to seek care?
Symptoms that warrant an assessment
A hormonal health consultation may be relevant if you have, for example:
hot flashes
night sweats
sleep disturbance
mood changes
difficulty concentrating or a feeling of “brain fog”
vaginal dryness or discomfort
pain during sex
urinary symptoms
decreased sexual desire
menstrual changes associated with perimenopause
symptoms that affect your quality of life
Perimenopause can begin several years before periods stop completely. Menopause is officially defined after 12 consecutive months without a menstrual period.3
Wondering whether your symptoms are related to perimenopause or menopause?
Some symptoms readily attributed to hormones can also be associated with other conditions. Depending on your clinical presentation, the NP may therefore assess different aspects of your health:
Cardiovascular health
Blood pressure, risk factors, personal and family history.
Metabolic health
Weight, blood glucose, cholesterol and other parameters when relevant.
Sleep and fatigue
Looking for other factors that may contribute to symptoms.
Sexual and genitourinary health
Dryness, pain, recurrent urinary tract infections or other symptoms associated with the genitourinary syndrome of menopause.
Bone health
Assessment of risk factors when the situation requires it.
Medication and lifestyle habits
Because treatment must fit into your reality and your overall health.
This approach helps avoid two extremes: automatically attributing every symptom to hormones or, conversely, downplaying symptoms that can considerably affect quality of life.
Understanding the treatment
Hormone therapy: what is it?
Menopausal hormone therapy mainly uses estrogens, with or without a progestogen depending on the clinical situation.
In a person who still has their uterus, a progestogen is generally needed with systemic estrogen-based treatment to protect the endometrium.2
Different routes of administration exist, including:
tablets
transdermal patches
gels
vaginal treatments
other regimens adapted to the situation
The choice of molecule, dose and route of administration is part of the individualized assessment.
Systemic hormone therapy or local treatment?
These are two different approaches.
Systemic
Systemic hormone therapy
It acts throughout the body and can be used, among other things, to treat hot flashes and night sweats.
Local
Local vaginal hormone treatment
A low dose of vaginal estrogen can be used for certain genitourinary symptoms such as dryness, vaginal discomfort or certain urinary symptoms.
Systemic exposure is much lower than with systemic hormone therapy.2
Your important questions
Safety, breast cancer, weight, testosterone: let’s talk frankly
Is hormone therapy safe?
The answer cannot simply be “yes” or “no.” The level of risk depends on, among other things:
age;
when treatment is started;
the type of hormone therapy;
the dose;
the route of administration;
medical history;
individual risk factors.
For most healthy women with symptoms who are under age 60 or within ten years of menopause, current recommendations generally consider the benefit-risk balance to be favourable in the absence of contraindications.1, 2
However, some situations call for particular caution or may constitute a contraindication. That is precisely why we favour a complete assessment before deciding on treatment.
What about breast cancer?
This is probably one of the most common concerns.
The risk varies depending on the type of hormone therapy, its duration and the patient’s individual profile. Current data show, among other things, that the risk is not the same with estrogen-only treatment as with certain estrogen-progestogen combinations.2
We therefore prefer to avoid simplistic messages such as “hormones cause cancer” or, conversely, “hormones are risk-free.”
The right approach is to individually assess each patient’s potential benefits, risks and history.
Does hormone therapy cause weight loss?
Hormone therapy is not a weight loss treatment.
Weight changes observed around menopause can be influenced by several factors: aging, muscle mass, sleep, physical activity, diet and metabolic changes.
Available data do not show that hormone therapy causes weight gain; however, it should not be prescribed primarily for the purpose of losing weight.2
At Clinique IPS du Palais, weight management can be addressed separately when necessary in order to assess the overall metabolic situation.
What about testosterone?
Testosterone is not a general treatment for fatigue, aging or all the symptoms of menopause.
Current recommendations mainly support its use, in certain properly assessed postmenopausal women, in the context of hypoactive sexual desire disorder.4
A clinical assessment is therefore necessary before considering this type of treatment.
Our care pathway
Three appointments, at your own pace
1
First consultation
60 minutes
395 $
This appointment allows us to take the time needed to understand your situation. It includes, among other things:
your current symptoms;
your menstrual and hormonal history;
your medical and family history;
your medications;
your cardiovascular and metabolic health;
your lifestyle habits;
your concerns and goals;
an explanation of the available treatment options.
Depending on your situation, the NP may:
order investigations;
recommend certain examinations;
suggest changes to treatment;
or start treatment as early as this first consultation when the clinical assessment allows this to be done appropriately.
2
Second consultation
45 minutes
295 $
This appointment makes it possible, among other things:
to review investigation results;
to assess the response to treatment if it has already been started;
to discuss adverse effects;
to adjust treatment;
to answer new questions that have come up since the first appointment.
3
Follow-up consultation
30 minutes
195 $
Often held a few months later, it makes it possible to assess:
how symptoms have evolved;
treatment tolerance;
its effectiveness;
new medical issues;
the need for adjustment.
The frequency of follow-ups is then adapted to each patient’s situation.
Already on hormone therapy?
You can also consult if treatment was started elsewhere
The goal is not to systematically restart all your care, but to understand your current situation before suggesting next steps.
The NP can review with you:
your current treatment
its effectiveness
persistent symptoms
side effects
doses and routes of administration
your risk factors
whether to continue or adjust your treatment
What sets us apart
Seeing the person before seeing the hormones
Marie-Claude Tessier and Virginie JacquesYour PHCNPs in hormonal health
At Clinique IPS du Palais, our approach to hormonal health rests on a simple conviction:
a woman who consults for hormonal symptoms should not be reduced to her hormones.
Our team seeks to understand your health as a whole. Hormone therapy can be an excellent option for some people. For others, a different approach will be more appropriate. And sometimes, several issues need to be addressed at the same time.
Our responsibility is to present the available options to you, explain their benefits and risks, and then build with you a strategy tailored to your situation.
Frequently asked questions
Your questions about hormonal health
Do I absolutely have to take hormones?
No. A hormonal health consultation does not automatically mean that hormone therapy will be prescribed. Hormonal and non-hormonal options can be discussed depending on your situation.1
Do I need to have blood tests before my appointment?
Not necessarily. Tests are ordered when they are relevant to your clinical situation. Your NP will determine whether investigations are needed.
Can I start treatment at the first appointment?
In some situations, yes. If the assessment is sufficiently complete and no prior investigation is needed, treatment can sometimes be started as early as the first consultation.
Is it only for postmenopausal women?
No. The consultation can also concern perimenopause, that is, the transition period leading up to menopause.
Can all menopause symptoms be treated with hormones?
No. Hormone therapy is particularly effective for certain symptoms such as hot flashes and night sweats, but it is not indicated to systematically treat all the changes associated with aging or menopause.2
Personalized care
You do not need to know before your appointment whether hormone therapy is right for you. That is precisely the purpose of the consultation: to understand what you are experiencing, assess your health as a whole, explain the options and determine with you the most appropriate care.
Society of Obstetricians and Gynaecologists of Canada (SOGC). Directive clinique no 422a : Ménopause — symptômes vasomoteurs, agents thérapeutiques d’ordonnance, médecines douces et complémentaires, nutrition et mode de vie. Journal of Obstetrics and Gynaecology Canada, 2021. jogc.com — see also the SOGC position statement (November 2025).
Faubion SS, Crandall CJ, Davis L, et al. The 2022 hormone therapy position statement of The North American Menopause Society (now The Menopause Society). Menopause, 2022;29(7):767-794. journals.lww.com
Government of Canada, Department of National Defence. Guide SFD sur la ménopause.canada.ca
Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The Journal of Clinical Endocrinology & Metabolism, 2019;104(10):4660-4666. academic.oup.com
The information on this page is provided for information purposes only and does not replace a consultation with a health professional.